<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Reports of Biochemistry and Molecular Biology</title>
<title_fa></title_fa>
<short_title>rbmb.net</short_title>
<subject>Basic Sciences</subject>
<web_url>http://rbmb.net</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2322-3480</journal_id_issn>
<journal_id_issn_online>2322-3480</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61882/rbmb</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1401</year>
	<month>1</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2022</year>
	<month>4</month>
	<day>1</day>
</pubdate>
<volume>11</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>O6-Methylguanine-DNA Methyltransferase and ATP-Binding Cassette Membrane Transporter G2 Promotor Methylation: Can Predict the Response to Chemotherapy in Advanced Breast Cancer?</title>
	<subject_fa>زیست شناسی ملکولی</subject_fa>
	<subject>Molecular Biology</subject>
	<content_type_fa>مقالات اصلی</content_type_fa>
	<content_type>Original Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;em&gt;&lt;strong&gt;Background:&lt;/strong&gt;&lt;/em&gt; ATP-binding cassette membrane transporter G2 (ABCG2) gene is one of transporter&amp;nbsp;family and well characterized for their association with chemoresistance. Promoter methylation is a&amp;nbsp;mechanism for regulation of gene expression. O6-Methyl guanine DNA methyl transferase (MGMT)&amp;nbsp;gene plays a fundamental role in DNA repair. MGMT has the ability to remove alkyl adducts from&amp;nbsp;DNA at the O6 position of guanine. Alkylating agents exert their function through adding these alkyls&amp;nbsp;adducts to DNA leading to cell death unless it is repaired by MGMT. MGMT promoter was found to&amp;nbsp;be methylated in several malignancies. The aim of the present work is to study the relation of MGMT&amp;nbsp;and ABCG2 promoter methylation status in advanced breast cancer patients to response to&amp;nbsp;cyclophosphamide&amp;ndash;doxorubicin (AC) based therapeutic regime.&lt;br&gt;
&lt;br&gt;
&lt;strong&gt;&lt;em&gt;Methods:&lt;/em&gt;&lt;/strong&gt; This retrospective study included Forty-two female patients with advanced breast cancer&amp;nbsp;assessed before receiving chemotherapy and after the completion of regimens. They were grouped into&amp;nbsp;responders and non-responders according to RECIST criteria. Methylation analysis of MGMT and&lt;br&gt;
ABCG2 genes were performed on breast cancer tissues.&lt;br&gt;
&lt;br&gt;
&lt;strong&gt;&lt;em&gt;Results:&lt;/em&gt;&lt;/strong&gt; MGMT promoter was methylated in 40.5% of the cases. ABCG2 promoter was methylated in&amp;nbsp;14.3% of cases. There was no statistically significant association between MGMT and ABCG2&amp;nbsp;promoter methylation status and clinicopathological parameters. There was statistically significant&amp;nbsp;association between methylation status of both promoters and response to AC when followed by&amp;nbsp;Taxane.&lt;br&gt;
&lt;br&gt;
&lt;strong&gt;&lt;em&gt;Conclusions:&lt;/em&gt;&lt;/strong&gt; Methylation of MGMT and ABCG2 promoters combined could be a&amp;nbsp;potential predictive&amp;nbsp;factor for response to cyclophosphamide-doxorubicin based therapeutic regime.</abstract>
	<keyword_fa></keyword_fa>
	<keyword>ABCG2, Breast cancer, Chemoresistance, DNA methylation, MGMT.</keyword>
	<start_page>20</start_page>
	<end_page>29</end_page>
	<web_url>http://rbmb.net/browse.php?a_code=A-10-847-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Sara</first_name>
	<middle_name></middle_name>
	<last_name>Ahmed Aglan</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460012312</code>
	<orcid>100319475328460012312</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Chemical Pathology, Medical Research Institute, Alexandria University, Alexandria, Egypt.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Ahmad</first_name>
	<middle_name></middle_name>
	<last_name>Mohamad Zaki</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460012313</code>
	<orcid>100319475328460012313</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Chemical Pathology, Medical Research Institute, Alexandria University, Alexandria, Egypt.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Amel</first_name>
	<middle_name></middle_name>
	<last_name>Sobhy El Sedfy</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460012314</code>
	<orcid>100319475328460012314</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Pathology, Medical Research Institute, Alexandria University, Alexandria, Egypt.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Heba</first_name>
	<middle_name></middle_name>
	<last_name>Gaber El-Sheredy</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>heba.gaber99@yahoo.com.</email>
	<code>100319475328460012315</code>
	<orcid>100319475328460012315</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Cancer Management and Research, Medical Research Institute, Alexandria University, Alexandria, Egypt.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Ola</first_name>
	<middle_name></middle_name>
	<last_name>Hussein Elgaddar</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460012316</code>
	<orcid>100319475328460012316</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Chemical Pathology, Medical Research Institute, Alexandria University, Alexandria, Egypt.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
